# bioAffinity Technologies, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:eb0eceea-d83d-49ea-9992-3f954e45460f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/bioaffinity-technologies-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-24T04:48:12.829505+00:00 | | Last reviewed | 2026-10-24T04:48:12.829505+00:00 | ## Identity - Legal name: bioAffinity Technologies, Inc. - Display name: bioAffinity Technologies, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-24T22:44:48.986228+00:00 | | Completeness | 0.409 | | Record Quality | 0.835 | | Directors | 6 | | Committees | 6 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Jamie Platt: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:5 - John J. Oppenheimer: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:6 - Maria Zannes: Director. Status: current. Independent: false. Since: 2014-01-01. claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:7 - Peter Knight: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:8 - Roberto Rios: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:9 - Steven Girgenti: Director. Status: current. Independent: false. Since: 2014-01-01. claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:10 ## Committees - Audit (audit). Chair: Roberto Rios. Members: Roberto Rios (chair, current); Jamie Platt (member, current); Peter Knight (member, current). committee_id=alpha:committee:bioaffinity-technologies-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Roberto Rios (member, current). committee_id=alpha:committee:bioaffinity-technologies-inc:audit-chair-compensation - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Peter Knight (member, current). committee_id=alpha:committee:bioaffinity-technologies-inc:audit-compensation-chair - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Jamie Platt (member, current). committee_id=alpha:committee:bioaffinity-technologies-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: Peter Knight. Members: Peter Knight (chair, current); Roberto Rios (member, current). committee_id=alpha:committee:bioaffinity-technologies-inc:compensation - Nominating and Governance (nominating_governance). Chair: Jamie Platt. Members: Jamie Platt (chair, current); John J. Oppenheimer (member, current). committee_id=alpha:committee:bioaffinity-technologies-inc:nominating-and-governance ## Executive leadership - James Michael Edwards: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:11 - Maria Zannes, JD: President, Chief Executive Officer, and Director [CEO]. Status: current. claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:12 - Timothy P. Zannes, JD: Executive Vice President, Secretary, and General Counsel [GC]. Status: current. claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:13 - Xavier Reveles: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:14 ## Governance events - CFO_CHANGED: James Michael Edwards executive of bioAffinity Technologies, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:u6y4n4n8yt86 - CEO_CHANGED: Maria Zannes, JD executive of bioAffinity Technologies, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1xxhdw1pt71zg - GC_CHANGED: Timothy P. Zannes, JD executive of bioAffinity Technologies, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:14j1zm1mdri55 - EXECUTIVE_APPOINTED: Xavier Reveles executive of bioAffinity Technologies, Inc., effective 2026-03-16. Effective: 2026-03-16. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1gaaw3211cy076 - DIRECTOR_APPOINTED: John J. Oppenheimer seat on bioAffinity Technologies, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:jf00191rebw9h - DIRECTOR_APPOINTED: Roberto Rios seat on bioAffinity Technologies, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:e5b0n016xjlse - COMMITTEE_CREATED: Audit · Chair; Compensation committee of bioAffinity Technologies, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1r9o1uewff50a - COMMITTEE_MEMBER_ADDED: Roberto Rios member of Audit · Chair; Compensation, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1634wx41ru7x38 - COMMITTEE_MEMBER_ADDED: John J. Oppenheimer member of Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:15otvgqvmxf12 - DIRECTOR_APPOINTED: Jamie Platt seat on bioAffinity Technologies, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:sdm7ns1r8u0ko - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of bioAffinity Technologies, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:taai9ad04eqs - COMMITTEE_MEMBER_ADDED: Jamie Platt member of Audit; Nominating and Governance · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:qe9uo9a0f4n5 - DIRECTOR_APPOINTED: Peter Knight seat on bioAffinity Technologies, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1llvw8n1v1h9ax - COMMITTEE_CREATED: Audit; Compensation · Chair committee of bioAffinity Technologies, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1egqoib16kkts1 - COMMITTEE_MEMBER_ADDED: Peter Knight member of Audit; Compensation · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1r928sl1n7k4an - DIRECTOR_APPOINTED: Maria Zannes seat on bioAffinity Technologies, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1fxp8rqpo6yfq - DIRECTOR_APPOINTED: Steven Girgenti seat on bioAffinity Technologies, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-24T04:48:12.829505+00:00. event_id=alpha:event:transition:1vhc03qyc21a4 ## Scoped resources - `alpha://company/bioaffinity-technologies-inc` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record - `alpha://company/bioaffinity-technologies-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=identity - `alpha://company/bioaffinity-technologies-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=corporate-structure - `alpha://company/bioaffinity-technologies-inc/board` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=board - `alpha://company/bioaffinity-technologies-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=committees - `alpha://company/bioaffinity-technologies-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=leadership - `alpha://company/bioaffinity-technologies-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=ownership - `alpha://company/bioaffinity-technologies-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=financials - `alpha://company/bioaffinity-technologies-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=capital-structure - `alpha://company/bioaffinity-technologies-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=compensation - `alpha://company/bioaffinity-technologies-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=governance - `alpha://company/bioaffinity-technologies-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=shareholder-governance - `alpha://company/bioaffinity-technologies-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=audit - `alpha://company/bioaffinity-technologies-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=legal - `alpha://company/bioaffinity-technologies-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=risk - `alpha://company/bioaffinity-technologies-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=cyber - `alpha://company/bioaffinity-technologies-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=ai-governance - `alpha://company/bioaffinity-technologies-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=agents - `alpha://company/bioaffinity-technologies-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=ecosystem - `alpha://company/bioaffinity-technologies-inc/events` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=events - `alpha://company/bioaffinity-technologies-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=relationships - `alpha://company/bioaffinity-technologies-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=assessments - `alpha://company/bioaffinity-technologies-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:roberto-rios","name":"Roberto Rios"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jamie-platt","name":"Jamie Platt"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:peter-knight","name":"Peter Knight"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:peter-knight","name":"Peter Knight"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:roberto-rios","name":"Roberto Rios"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:jamie-platt","name":"Jamie Platt"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:john-j-oppenheimer","name":"John J. Oppenheimer"},"source_id":"board_seats"}` ## Leadership - Jamie Platt: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204. - John J. Oppenheimer: Director, Nominating and Governance. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204. - Maria Zannes: Director. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204. - Peter Knight: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204. - Roberto Rios: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204. - Steven Girgenti: Director. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:10. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204. - James Michael Edwards: Chief Financial Officer. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:11. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:626912497ff8ed81c9896ab7aaed901236e394f0a3f197195cb3eaff152a0f89. - Maria Zannes, JD: President, Chief Executive Officer, and Director. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:12. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d529d4bc87c787f95c59fef662e34ab1330fd79a7100a101cf31d7ee50a9d456. - Timothy P. Zannes, JD: Executive Vice President, Secretary, and General Counsel. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:13. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3decf238581b63d0252e9896afb936058a7d75c77ed099630ca81b7512f3aa6. - Xavier Reveles: Chief Operating Officer. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:leadership_role:14. Valid from: 2026-03-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:940fc8dee1bafbf113bdf195946044c5357acc9ada96f7259318a4f381349a92. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Roberto Rios; Members Roberto Rios (Chair); Jamie Platt; Peter Knight. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Compensation: Chair Peter Knight; Members Peter Knight (Chair); Roberto Rios. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Nominating and Governance: Chair Jamie Platt; Members Jamie Platt (Chair); John J. Oppenheimer. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - bioAffinity Technologies, Inc.. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:106386e5015b8c3b68026bfffa332e830e32f1b8a9d03033a6b7d016adc119f9. ## Entity Status - Public listing published. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:106386e5015b8c3b68026bfffa332e830e32f1b8a9d03033a6b7d016adc119f9. ## Published Fact - US. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:106386e5015b8c3b68026bfffa332e830e32f1b8a9d03033a6b7d016adc119f9. ## Committee Appointment - Roberto Rios: chair, Audit. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Jamie Platt: member, Audit. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Peter Knight: member, Audit. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Peter Knight: chair, Compensation. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Roberto Rios: member, Compensation. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - Jamie Platt: chair, Nominating and Governance. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. - John J. Oppenheimer: member, Nominating and Governance. Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e. ## Security Listing - BIAF (NASDAQ). Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:106386e5015b8c3b68026bfffa332e830e32f1b8a9d03033a6b7d016adc119f9. - BIAFW (NASDAQ). Claim: alpha:claim:company:eb0eceea-d83d-49ea-9992-3f954e45460f:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:106386e5015b8c3b68026bfffa332e830e32f1b8a9d03033a6b7d016adc119f9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:106386e5015b8c3b68026bfffa332e830e32f1b8a9d03033a6b7d016adc119f9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/bioaffinity-technologies-inc). - alpha:projection-evidence:document:6fe3c8ed59073138311d8d3c0467fa6ebbc7e6e26e9930e51082ba0091532204: [bioAffinity Technologies, Inc. DEF 14A 2026-03-16](https://www.sec.gov/Archives/edgar/data/1712762/000149315226010314/formdef14a.htm). - alpha:projection-evidence:document:626912497ff8ed81c9896ab7aaed901236e394f0a3f197195cb3eaff152a0f89: [BIAF DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1712762/000149315226010314/formdef14a.htm). - alpha:projection-evidence:document:d529d4bc87c787f95c59fef662e34ab1330fd79a7100a101cf31d7ee50a9d456: [BIAF DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1712762/000149315226010314/formdef14a.htm). - alpha:projection-evidence:document:f3decf238581b63d0252e9896afb936058a7d75c77ed099630ca81b7512f3aa6: [BIAF DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1712762/000149315226010314/formdef14a.htm). - alpha:projection-evidence:document:940fc8dee1bafbf113bdf195946044c5357acc9ada96f7259318a4f381349a92: [BIAF DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1712762/000149315226010314/formdef14a.htm). - alpha:projection-evidence:0eac3dc796adea455d6716ccced543582264d5f3a9c12e25921f41058f1d2e6e: [Audit](https://www.sec.gov/Archives/edgar/data/1712762/000149315226010314/formdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/bioaffinity-technologies-inc) - [Public Markdown](https://registry.alpha.ac/companies/bioaffinity-technologies-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/bioaffinity-technologies-inc?format=jsonld) - MCP resource: `alpha://companies/bioaffinity-technologies-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-24T22:44:48.696828+00:00; recorded 2026-10-24T22:44:48.696828+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.